Who owns Evaxion Biotech A/S ADR?
- Ticker: EVAX
- CUSIP Number: 29970r303
Tip: Access positions for across all investors
Analyze quarterly positions in Evaxion Biotech A/S with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Evaxion Biotech A/S stock
Who bought or sold Evaxion Biotech A/S ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 75k | $356k | -7% | Dec 2025 |
|
| Point72 Asset Management | 33k | $158k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 21k | $101k | 124% | Dec 2025 |
|
| Stonepine Capital Management | 20k | $95k | 100% | Dec 2025 |
|
| Boothbay Fund Management | 18k | $88k | -22% | Dec 2025 |
|
| Wesbanco Trust And Investments | 10k | $48k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 8.0k | $38k | 100% | Dec 2025 |
|
| GAMMA Investing | 3.8k | $18k | 16% | Dec 2025 |
|
| UBS Group | 3.2k | $15k | 321600% | Dec 2025 |
|
| EverSource Wealth Advisors | 2.7k | $13k | 100% | Dec 2025 |
|
| SBI Securities | 62.00 | $296.000400 | -5% | Dec 2025 |
|
| Bessemer | 18.00 | $0 | 0% | Dec 2025 |
|